Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total control versus well-controlled asthma strategy with Seretide
2005-002950-23Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salmeterol + fluticasone in asthma (2 arms), sponsored by GSK. Primary endpoint: Mean change in PC20 methacholine after 24 weeks. Started Oct 2005; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-002950-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002950-23.